Ultragenyx Pharmaceutical reported $3.14M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 5.21M 0.51M
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
Alnylam Pharmaceuticals ALNY:US $ 30.26M 7.23M
Biocryst Pharmaceuticals BCRX:US $ 0.34M 5.54M
Biomarin Pharmaceutical BMRN:US $ 127.06M 6.9M
Bluebird Bio BLUE:US $ 15.3M 13.02M
Epizyme EPZM:US $ 2.49M 361K
Esperion Therapeutics ESPR:US $ 1.8M 16K
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Insmed INSM:US $ 10.84M 993K
IONIS PHARMACEUT IONS:US $ 2.96M 0.38M
Karyopharm Therapeutics KPTI:US $ 1.14M 205K
Kyowa Hakko Kirin 4151:JP Y 18856M 3536M
MacroGenics MGNX:US 22K 5K
Moderna Inc MRNA:US 750M 557M
Neurocrine Biosciences NBIX:US $ 3.1M 0.2M
Ptc Therapeutics PTCT:US $ 7.36M 1.75M
Puma Biotechnology PBYI:US $ 11.97M 17.59M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M
Sarepta Therapeutics SRPT:US $ 19.52M 2.83M
Ultragenyx Pharmaceutical RARE:US $ 3.14M 2.05M
Vertex Pharmaceuticals VRTX:US $ 227.97M 35.64M